Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MULLER TH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 53 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Muller, TH; Wagner, FF; Trockenbacher, A; Eicher, NI; Flegel, WA; Schonitzer, D; Schunter, F; Gassner, C
      PCR screening for common weak D types shows different distributions in three Central European populations

      TRANSFUSION
    2. Muller, TH
      Inhibition of thrombus formation by low-dose acetylsalicylic acid, dipyridamole, and their combination in a model of platelet-vessel wall interaction

      NEUROLOGY
    3. Wagner, FF; Frohmajer, A; Ladewig, B; Eicher, NI; Lonicer, CB; Muller, TH; Siegel, MH; Flegel, WA
      Weak D alleles express distinct phenotypes

      BLOOD
    4. Metzner, B; Dirks, R; Gebauer, W; Reschke, D; Muller, TH; Ost, E; Reichert, D; Rosien, B; del Valle, F; Zirpel, I; Hellkamp, J; Kohse, KP; Schunter, F; Illiger, HJ
      Early infectious complications after high-dose-therapy and autologous blood stem cell transplantation

      ONKOLOGIE
    5. Wagner, FF; Gassner, C; Muller, TH; Schonitzer, D; Schunter, F; Flegel, WA
      Molecular basis of weak D phenotypes

      BLOOD
    6. Muller, TH
      Pharmacological reasons to combine low-dose acetylsalicylic acid with dipyridamole

      INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
    7. Flegel, WA; Wagner, FF; Muller, TH; Gassner, C
      Rh phenotype prediction by DNA typing and its application to practice

      TRANSFUSION MEDICINE
    8. Muller, TH; Schmidt, S; Schunter, F; Seghatchian, MJ
      The timing of leuko-depletion of apheresis platelets with a Sepacell PLS-5A filter does not affect glycoprotein IIb/IIIa-dependent platelet function in vitro

      TRANSFUSION SCIENCE
    9. OHEIM M; NARAGHI M; MULLER TH; NEHER E
      2 DYE 2 WAVELENGTH EXCITATION CALCIUM IMAGING - RESULTS FROM BOVINE ADRENAL CHROMAFFIN CELLS

      Cell calcium
    10. WAGNER FF; GASSNER C; MULLER TH; SCHRONITZER D; SCHUNTER F; FLEGEL WA
      THE MOLECULAR CAUSES OF WEAK-D

      Transfusion
    11. MULLER TH; SCHMIDT S; DOSCHER A; SEGHATCHIAN J; SCHUNTER F
      SINGLE-NEEDLE VERSUS DOUBLE-NEEDLE PLATELETPHERESIS (AMICUS) DOES NOTAFFECT PLATELET QUALITY IN-VITRO

      Transfusion
    12. MULLER TH; SCHMIDT S; SCHUNTER F; SEGHATCHIAN JM
      STORAGE OF APHERESIS PLATELETS IN DEFINED MEDIUM (LESS-THAN-10-PERCENT PLASMA) MAINTAINS ADEQUATE IN-VITRO QUALITY

      Transfusion
    13. WAGNER FF; GASSNER C; MULLER TH; SCHONITZER D; SCHUNTER F; FLEGEL WA
      3 MOLECULAR-STRUCTURES CAUSE RHESUS-D CATEGORY-VI PHENOTYPES WITH DISTINCT IMMUNOHEMATOLOGIC FEATURES

      Blood
    14. NARAGHI M; MULLER TH; NEHER E
      2-DIMENSIONAL DETERMINATION OF THE CELLULAR CA2+ BINDING IN BOVINE CHROMAFFIN CELLS

      Biophysical journal
    15. MULLER TH; DOSCHER A; SCHUNTER F; SCOTT CS
      MANUAL AND AUTOMATED METHODS FOR THE DETERMINATION OF LEUKOCYTE COUNTS AT EXTREME LOW-LEVELS - COMPARATIVE-EVALUATION OF THE NAGEOTTE CHAMBER AND THE ABBOTT CELL DYN-3500 ANALYZER

      Transfusion science
    16. MULLER TH; DOSCHER A; SCHUNTER F; SEGHATCHIAN MJ
      SOLUBLE P-SELECTIN DURING THE STORAGE OF APHERESIS PLATELET CONCENTRATES

      Platelets
    17. GUTH BD; MULLER TH
      DTTX30, A COMBINED THROMBOXANE RECEPTOR ANTAGONIST AND THROMBOXANE SYNTHETASE INHIBITOR, PREVENTS CORONARY-THROMBOSIS IN ANESTHETIZED DOGS

      Basic research in cardiology
    18. GUTH BD; SEEWALDTBECKER E; HIMMELSBACH F; WEISENBERGER H; MULLER TH
      ANTAGONISM OF THE GPIIB IIIA RECEPTOR WITH THE NONPEPTIDIC MOLECULE BIBU52 - INHIBITION OF PLATELET-AGGREGATION IN-VITRO AND ANTITHROMBOTICEFFICACY IN-VIVO/

      Journal of cardiovascular pharmacology
    19. MULLER TH; EISING EG; REINERS C; PRZUNTEK H; JACOB M; KUHN W
      2-[I-123]-IODOLISURIDE SPET VISUALIZES DOPAMINERGIC LOSS IN DE-NOVO PARKINSONIAN-PATIENTS - IS IT A MARKER OF STRIATAL PRESYNAPTIC DEGENERATION

      Nuclear medicine communications
    20. MULLER TH
      PHARMACODYNAMIC MODELS TO EVALUATE ANTITHROMBOTICS IN CLINICAL-PHARMACOLOGY

      Journal of clinical pharmacology
    21. NARJES H; MULLER TH; WEISENBERGER H; GUTH B; BRICKL R
      INHIBITION OF PLATELET-AGGREGATION AS A SURROGATE MARKER

      Journal of clinical pharmacology
    22. MULLER TH; DOSCHER A; SCHUNTER F
      GENOTYPING OF THE HUMAN PLATELET ANTIGEN-1 BY ELISA DETECTION OF ALLELE-SPECIFIC AMPLICONS

      Vox sanguinis
    23. FLEGEL WA; MULLER TH; SCHUNTER F; GASSNER C; SCHONITZER D; WAGNER FF
      D-CATEGORY-VI TYPE-III - A D-CE(3-6)-D HYBRID PROTEIN WITH NORMAL RHDANTIGEN DENSITY ON RED-CELLS

      Transfusion
    24. GASSNER C; MULLER TH; WAGNER FF; FLEGEL WA; SCHONITZER D
      RHESUS-C TYPING BY POLYMERASE CHAIN-REACTION USING SEQUENCE-SPECIFIC PRIMERS - REALIZATION OF MEDIUM RESOLUTION RH-DNA-TYPING

      Transfusion
    25. GASSNER C; SCHMARDA A; KILGANOGLER S; JENNYFELDKIRCHER B; RAINER E; MULLER TH; WAGNER FF; FLEGEL WA; SCHONITZER D
      RHD CE TYPING BY POLYMERASE CHAIN-REACTION USING SEQUENCE-SPECIFIC PRIMERS/

      Transfusion
    26. MULLER TH; SWANDULLA D; ZEILHOFER HU
      SYNAPTIC CONNECTIVITY IN CULTURED HYPOTHALAMIC NEURONAL NETWORKS

      Journal of neurophysiology
    27. NARJES H; MULLER TH; WEISENBERGER H; TANSWELL P; DEICHSEL G; SU CAPF
      INHIBITION OF PLATELET-FUNCTION, PK-PD RELATIONSHIP AND TOLERABILITY OF DT-TX-30-SE, A NOVEL COMBINED TXA(2) PGH(2) RECEPTOR BLOCKER AND THROMBOXANE SYNTHETASE INHIBITOR, IN HEALTHY-VOLUNTEERS/

      Clinical pharmacology and therapeutics
    28. NARJES HH; WEISENBERGER H; GUTH B; MULLER TH; DEICHSEL G; KRAUSE J; SU CAPF
      SAFETY, PHARMACOKINETICS AND DYNAMICS OF THE ORAL GPIIB IIIA INHIBITOR LEFRADAFIBAN IN HEALTHY-VOLUNTEERS/

      Circulation
    29. MULLER TH; WEISENBERGER H; BRICKL R; NARJES H; HIMMELSBACH F; KRAUSE J
      PROFOUND AND SUSTAINED INHIBITION OF PLATELET-AGGREGATION BY FRADAFIBAN, A NONPEPTIDE PLATELET GLYCOPROTEIN IIB IIIA ANTAGONIST, AND ITS ORALLY-ACTIVE PRODRUG, LEFRADAFIBAN, IN MEN/

      Circulation
    30. MULLER TH; SCHMIDT S; KLEINSTRUCKMEIER A; SCHUNTER F
      PLASMA ONLY AFTER AN EXCESSIVE METHYLENE-BLUE PHOTOTREATMENT INHIBITSPLATELET-AGGREGATION IN-VITRO

      Transfusion
    31. ZEILHOFER HU; MULLER TH; SWANDULLA D
      CALCIUM-CHANNEL TYPES CONTRIBUTING TO EXCITATORY AND INHIBITORY SYNAPTIC TRANSMISSION BETWEEN INDIVIDUAL HYPOTHALAMIC NEUTRONS

      Pflugers Archiv
    32. SCHMID E; MULLER TH; BUDZINSKI RM; BINDER K; PFIZENMAIER K
      SIGNALING BY E-SELECTIN AND ICAM-1 INDUCES ENDOTHELIAL TISSUE FACTOR PRODUCTION VIA AUTOCRINE SECRETION OF PLATELET-ACTIVATING-FACTOR AND TUMOR-NECROSIS-FACTOR-ALPHA

      Journal of interferon & cytokine research
    33. NARJES H; WEISENBERGER H; MULLER TH; DEICHSEL G; KRAUSE J
      TOLERABILITY AND PLATELET FIBRINOGEN RECEPTOR OCCUPANCY (FRO) AFTER ORAL TREATMENT WITH BIBU-104-XX IN HEALTHY-VOLUNTEERS

      Thrombosis and haemostasis
    34. MULLER TH; WEISENBERGER H; BRICKL R; KIRCHNER M; NARJES H; HIMMELSBACH F; GUTH B; KRAUSE J
      PHARMACODYNAMICS AND PHARMACOKINETICS OF BIBU-52, A PLATELET GLYCOPROTEIN (GP) IIB IIIA ANTAGONIST, AND ITS ORALLY-ACTIVE PRODRUG BIBU-104 IN MAN/

      Thrombosis and haemostasis
    35. MULLER TH; WEISENBERGER H; BRICKL R; RUHR K; NARJES H; HIMMELSBACH F
      ANTI-AGGREGATORY PROFILE OF THE PLATELET GLYCOPROTEIN (GP) IIB IIIA ANTAGONIST BIBU-52 IN EX-VIVO STUDIES IN MAN/

      Thrombosis and haemostasis
    36. SCHMID E; MULLER TH; BUDZINSKI RM; PFIZENMAIER K; BINDER K
      LYMPHOCYTE ADHESION TO HUMAN ENDOTHELIAL-CELLS INDUCES TISSUE FACTOR EXPRESSION VIA A JUXTACRINE PATHWAY

      Thrombosis and haemostasis
    37. HIMMELSBACH F; AUSTEL V; GUTH B; LINZ G; MULLER TH; PIEPER H; SEEWALDTBECKER E; WEISENBERGER H
      DESIGN OF HIGHLY POTENT NONPEPTIDIC FIBRINOGEN RECEPTOR ANTAGONISTS

      European journal of medicinal chemistry
    38. NARJES H; MULLER TH; WEISENBERGER H; TANSWELL P; DEICHSEL G; SU CAPF
      PHARMACODYNAMICS OF DTTX-30-SE, A TXA(2) PGH(2) RECEPTOR BLOCKER AND THROMBOXANE (TX) SYNTHETASE INHIBITOR, AFTER MULTIPLE ORAL DOSING IN MAN/

      Clinical pharmacology and therapeutics
    39. PARTRIDGE LD; MULLER TH; SWANDULLA D
      CALCIUM-ACTIVATED NONSELECTIVE CHANNELS IN THE NERVOUS-SYSTEM

      Brain research reviews
    40. SOYKA R; HECKEL A; NICKL J; EISERT W; MULLER TH; WEISENBERGER H
      6,6-DISUBSTITUTED HEX-5-ENOIC ACID-DERIVATIVES AS COMBINED THROMBOXANE A(2) RECEPTOR ANTAGONISTS AND SYNTHETASE INHIBITORS

      Journal of medicinal chemistry
    41. ZEILHOFER HU; MULLER TH; SWANDULLA D
      INHIBITION OF HIGH VOLTAGE-ACTIVATED CALCIUM CURRENTS BY L-GLUTAMATE RECEPTOR-MEDIATED CALCIUM INFLUX

      Neuron
    42. BINDER K; SCHMID E; CHRIST I; HILGARTH A; SCHURER J; MULLER TH
      ADHERENCE TO SUBENDOTHELIAL MATRIX IS A SUFFICIENT STIMULUS FOR HUMANPLATELETS TO BIND ANNEXIN-V AND TO INCREASE THROMBIN FORMATION

      Thrombosis and haemostasis
    43. GUTH BD; GERSTER U; KOCH V; EZEKOWITZ MD; MULLER TH
      INHIBITION OF ARTERIAL THROMBUS FORMATION WITH A COMBINED THROMBOXANEENDOPEROXIDE RECEPTOR-THROMBOXANE SYNTHETASE INHIBITOR (DTTX30) IN THE RABBIT ABDOMINAL-AORTA

      Thrombosis and haemostasis
    44. GUTH BD; DIETZE T; MULLER TH
      INHIBITION OF EPINEPHRINE-STIMULATED CORONARY THROMBUS FORMATION WITHA COMBINED THROMBOXANE ENDOPEROXIDE RECEPTOR-THROMBOXANE SYNTHETASE INHIBITOR (DTTX30)

      Thrombosis and haemostasis
    45. SCHMID E; BINDER K; MULLER TH
      THROMBUS INDUCED ENDOTHELIAL TISSUE FACTOR EXPRESSION IN-VITRO IS SIGNIFICANTLY ENHANCED BY HUMAN MONONUCLEAR LEUKOCYTES

      Thrombosis and haemostasis
    46. MULLER TH; SCHURER H; WALDMANN L; BAUER E; HIMMELSBACH F; BINDER K
      ORAL ACTIVITY OF BIBU-104, A PRODRUG OF THE NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BIBU-52, IN MICE AND MONKEYS

      Thrombosis and haemostasis
    47. GUTH BD; GERSTER U; KOCH V; MULLER TH
      INHIBITION OF RECURRENT ARTERIAL THROMBUS FORMATION IN GUINEA-PIGS BYTHE FIBRINOGEN RECEPTOR ANTAGONIST-BIBU52

      Thrombosis and haemostasis
    48. MULLER TH; GERSTER U; KOCH V; HIMMELSBACH F; GUTH BD
      BIBU-52, A NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST, INHIBITS ARTERIAL THROMBOSIS IN-VIVO MORE EFFECTIVELY THAN EITHER ASPIRIN OR HEPARIN

      Thrombosis and haemostasis
    49. MULLER TH; RUHR K; HIMMELSBACH F; SEEWALDTBECKER E
      THE NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST BIBU-52, IN CONTRAST TOASPIRIN, DOES NOT INTERFERE WITH THE MODULATION OF THROMBUS FORMATIONBY VASCULAR CELLS

      Thrombosis and haemostasis
    50. BINDER K; CHRIST I; SCHURER J; MULLER TH
      HETEROGENEITY IN BINDING OF ANNEXIN-V INDICATES FUNCTIONAL DIVERSITY IN THROMBIN FORMATION ON ACTIVATED PLATELETS

      Thrombosis and haemostasis
    51. MULLER TH; RUHR K
      COMBINED THROMBOXANE-SYNTHETASE INHIBITION AND THROMBOXANE-RECEPTOR ANTAGONISM BY DTTX 30 ENHANCES THE ANTITHROMBOTIC ACTIVITY OF HUMAN VASCULAR CELLS

      Thrombosis and haemostasis
    52. MULLER TH; PARTRIDGE LD; SWANDULLA D
      CALCIUM BUFFERING IN BURSTING HELIX PACEMAKER NEURONS

      Pflugers Archiv
    53. WAHLE P; MULLER TH; SWANDULLA D
      CHARACTERIZATION OF NEUROCHEMICAL PHENOTYPES IN CULTURED HYPOTHALAMICNEURONS WITH IMMUNOHISTOCHEMISTRY AND INSITU HYBRIDIZATION

      Brain research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 25/05/20 alle ore 04:42:45